Congressional Testimony 2005

-

December

12/13/2005 Controlled Substances
Robert J. Meyer, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

-

11/01/2005 Counterfeit Drugs
Randall W. Lutter, Ph.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources

-

09/29/2005 Impact of Direct-to-Consumer Drug Advertising on Seniors' Health and Health Care Costs
Rachel E. Behrman, M.D., M.P.H., before the Senate Special Committee on Aging
09/13/2005 FDA's Role in Preventing Prescription Drug Abuse
Robert J. Meyer, M.D., before the Senate Committee on Government Reform
09/07/2005 Prevention, Early Detection, and Treatment of Gynecological Cancers
Richard Pazdur, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources

-

07/20/2005 Food Counterterrorism Activities
Robert E. Brackett, Ph.D., before the Senate Committee on Agriculture, Nutrition and Forestry

-

06/14/2005 Bioengineered Foods
Robert E. Brackett, Ph.D., before the Senate Committee on Agriculture, Nutrition and Forestry

-

05/17/2005 Food Safety System
Robert E. Brackett, Ph.D., before the House Committee on Government Reform, Subcommittee on the Federal Workforce and Agency Organization
05/05/2005 Office of New Drugs/Office of Drug Safety
Steven Galson, M.D., M.P.H., before the House Committee on Goverment Reform
05/04/2005 Influenza Vaccine Supply
Jesse L. Goodman, M.D., M.P.H., before the House Committee on Energy and Commerce

-

03/17/2005 FDA Commissioner Confirmation Statement
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on Health, Education, Labor and Pensions
03/05/2005 Drug Safety/Drug Approval Process
Sandra L. Kweder, M.D., and Janet Woodcock, M.D., before the Senate Committee on Health, Education, Labor and Pensions

-

02/10/2005 Influenza Vaccine Needs
Jesse L. Goodman, M.D., M.P.H., before the House Committee on Government Reform

-